Seqens
  • About Us
    • About Seqens
    • New England Locations
    • Client Testimonials
    • Affiliations
  • R&D and Analytics
    • Research Development
    • Preclinical/Kilo Scale
    • Reaction Technologies
    • Analytical and Quality Control
  • API Manufacturing
    • API Manufacturing at Seqens
    • Controlled Substance API manufacturing
    • Cryogenic API Manufacturing
    • API Phase I – III
    • Commercial API Production
    • Quality Assurance / Regulatory
    • cGMP Medical Grade Polymers
    • Advanced Materials
  • Products
  • News
  • Contact Us
    • Accelerate your API manufacturing project
    • Download Our Brochure
    • Confidential Disclosure Agreement
  • Careers
    • View all open positions
Select Page

Mehdi Yazdi the Art of API Method Development

by SEQENS North America | Oct 12, 2018 | Analytical Methods, Blog, Video

 

Dr. Mehdi Yazdi Director of Analytical Services talks about the art of API method development at Seqens.

Related posts:

Manufacturing Generic Versions of Controlled Substances
Delivering Advanced Materials: All in A Day’s Work for Today’s CDMO
Want to know why early drug development costs so much?
Why the FDA and EMA want you to implement QbD
Eight Considerations to Reduce the Cost of Success in API Manufacturing
  • Follow
  • Follow
  • Follow
© 2023 Seqens North America | 9 Opportunity Way | Newburyport, MA 01950 Tel: (978) 462-5555 | inquiries@seqens.com
Terms and Conditions | Contact Us